## Abstract This study is an attempt to develop a simple search method for lead peptide candidates, which include constrained structures in a recognized sequence, using the design of a competitive inhibitor for HMG‐CoA reductase (HMGR). A structure‐functional analysis of previously synthesized pept
Modeling an active conformation for linear peptides and design of a competitive inhibitor for HMG-CoA reductase
✍ Scribed by Valeriy V. Pak; Minseon Koo; Min Jung Kim; Hye Jeong Yang; Lyubov Yun; Dae Young Kwon
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 415 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0952-3499
- DOI
- 10.1002/jmr.889
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
This study presents an approach that can be used to search for lead peptide candidates, including unconstrained structures in a recognized sequence. This approach was performed using the design of a competitive inhibitor for 3‐hydroxy‐3‐methylglutaryl CoA reductase (HMGR). In a previous design for constrained peptides, a head‐to‐tail cyclic structure of peptide was used as a model of linear analog in searches for lead peptides with a structure close to an active conformation. Analysis of the conformational space occupied by the peptides suggests that an analogical approach can be applied for finding a lead peptide with an unconstrained structure in a recognized sequence via modeling a cycle using fixed residues of the peptide backbone. Using the space obtained by an analysis of the bioactive conformations of statins, eight cyclic peptides were selected for a peptide library based on the YVAE sequence as a recognized motif. For each cycle, the four models were assessed according to the design criterion (“V” parameter) applied for constrained peptides. Three cyclic peptides (FGYVAE, FPYVAE, and FFYVAE) were selected as lead cycles from the library. The linear FGYVAE peptide (IC~50~ = 0.4 µM) showed a 1200‐fold increase the inhibitory activity compared to the first isolated LPYP peptide (IC~50~ = 484 µM) from soybean. Experimental analysis of the modeled peptide structures confirms the appropriateness of the proposed approach for the modeling of active conformations of peptides. Copyright © 2008 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract This study investigates a proposed design of a peptide sequence that is based on a bioactive conformation of statins that act as the competitive inhibitors of HMG–CoA for HMGR. To bridge these heterogeneous organic compounds, a conformational aspect relating to an analysis of the flexib